GSH-dependent redox regulation and antioxidant enzymes in the formation of resistance to doxorubicin in K562 human erythroleukemia cells.
Kalinina
E
E
Lab. Biochemistry & Biophysics of Cancer, Institute of Chemical Physics, Moscow, Russia.
Novichkova
M
M
Scherbak
N P
NP
Solomka
V
V
Saprin
A N
AN
D000970:Antineoplastic Agents / Q000494:pharmacology*; D002374:Catalase / Q000378:metabolism*; D004317:Doxorubicin / Q000494:pharmacology*; D019008:Drug Resistance, Neoplasm; D005978:Glutathione / Q000378:metabolism*; D005979:Glutathione Peroxidase / Q000378:metabolism; D051549:Glutathione S-Transferase pi; D005982:Glutathione Transferase / Q000378:metabolism; D006801:Humans; D007527:Isoenzymes / Q000378:metabolism; D020014:K562 Cells; D004915:Leukemia, Erythroblastic, Acute; D010084:Oxidation-Reduction; D013482:Superoxide Dismutase / Q000378:metabolism*
D000970:Antineoplastic Agents; D007527:Isoenzymes; D004317:Doxorubicin; D002374:Catalase; D005979:Glutathione Peroxidase; D013482:Superoxide Dismutase; C496556:GSTP1 protein, human; D051549:Glutathione S-Transferase pi; D005982:Glutathione Transferase; D005978:Glutathione